Emergent BioSolutions Will Manufacture AstraZeneca's COVID-19 Vaccine CandidateThe Motley Fool • 06/11/20
AstraZeneca Boosts Its COVID-19 Research with More Help From the Public SectorThe Motley Fool • 06/09/20
Gilead Reportedly Receives AstraZeneca Interest — Is GILD Stock A Buy?Investors Business Daily • 06/09/20
AstraZeneca's Acquisition of Gilead Would Create a COVID-19 Colossus -- but Don't Bet on Seeing It HappenThe Motley Fool • 06/09/20
Gilead Sciences Pops On Rumored Takeover Interest From AstraZenecaInvestors Business Daily • 06/08/20
Gilead's stock rallies and AstraZeneca falls, after reports of preliminary merger interest, which have been droppedMarket Watch • 06/08/20
Oxford Biomedica partners with VMIC to ramp up production of AstraZeneca’s experimental COVID-19 vaccineInvezz • 06/08/20
British Drug Maker AstraZeneca Approached Gilead With The Deal That Can Become The Biggest On The RecordBenzinga • 06/08/20